Press Releases
Invictus Opens TSX Venture Exchange Trading as GENE for the First Time
INVICTUS MD STRATEGIES CORP. is pleased to announce that , Gene Simmons, Chief Evangelist Officer for the company and its management team opened the trading day at the TSX Venture Exchange (TSXV). The appearance coincides with the company changing...
Press Releases
Envigo expands Livermore (USA) surgical facilities to meet rising demand from West Coast companies
Envigo is investing in an expansion of its surgical facility at its Livermore, California site in response to large market demand from West Coast customers. The new expanded capabilities will help create a West Coast Centre...
Press Releases
Agendia Announces CE Mark for NGS-Based MammaPrint® BluePrint® Kit Enhancing Access to Personalized Treatment for Breast Cancer Patients in Europe
Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announces that its next-generation sequencing (NGS)-based MammaPrint® BluePrint® Breast Cancer Recurrence and Molecular Subtyping Kit is now CE marked, enabling the Company to commercialize the device in...
Press Releases
Introducing SMi’s6thannual conference on Pharmaceutical Freeze Drying Technologythis June 2018
SMi Group are delighted to announce the 6thannual Pharmaceutical Freeze Drying Technology conference, being held this June 2018! Read on for a massive £400 off. Optimising Pharmaceutical Technology Through Innovations & Novel Approaches In Freeze Drying...
Press Releases
Introducing SMi’s5th conference on Drug Safety 2018 this June
Drug Safety 2018 aims to discuss the latest findings and current thinking on pharmacovigilance. Importantly, it will address the newest regulatory updates and interpretations of them, including the impact of the vital and much awaited Clinical Trial Regulations. ...
Press Releases
Discover Novel Based Vial Based Technology, Presented by Roche this May
Building on the success of SMi's 10th Annual Flagship Conference Pre-Filled Syringes, SMi are thrilled to present the launch of their Injectable Drug Delivery conference being held at Holiday Inn, Kensington Forum, London, on the 16th – 17th May...
Press Releases
Sarepta Therapeutics gazes FDA approval of Golodirsen (SRP-4053) in Patients with Duchenne Muscular Dystrophy (DMD) Amenable to Skipping Exon 53
Sarepta Therapeutics, Inc , a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare neuromuscular diseases. Announced that it recently received final minutes from a February 2018 Type C...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read